Slideshow
Author(s):
New research found over a quarter of children with treatment-refractory epilepsy sustained treatment response to CBD over four years.
FDA Expands Diazepam Nasal Spray Indication to Treat Ages 2 to 5
Episode 139: Sleep and Seizures: Emerging Insights From AAN 2025
Phase 3 Study to Test 1st Generation Antihistamine EPX-100 in Lennox-Gastaut Syndrome
Episode 136: Raising Epilepsy Awareness for Purple Day
Breaking the Stigma: Improving Epilepsy Awareness and Care
Epilepsy Unveiled: Addressing Myths, Treatment Gaps, and New Innovations